2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow ImmuneMed, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, Pharmacokinetics of hzVSf-v13 in Healthy Adults (Intravenous and Subcutaneous Administration) hzVSF-v13 (intravenous, single dose), hzVSF-v13 (subcutaneous, single dose), hzVSF-v13 (intravenous, multiple dose) - Healthy Volunteers | Phase 1 | Completed | ImmuneMed, Inc. | 72 | 2020-09-16 | 2024-02-15 |
| Safety, Tolerability, Pharmacokinetic Characteristics of hzVSF-v13 in Healthy Male Volunteers hzVSF-v13, Placebo - Healthy | Phase 1 | Completed | ImmuneMed, Inc. | 56 | 2018-11-20 | 2021-04-27 |
Saline Solution (2) · Injections, Subcutaneous (1)
Australia (1) · South Korea (1)
In-Jin Jang, M.D (1)